|
FY2025
12 months to Sep 30, 2025
|
FY2024
12 months to Sep 30, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 30, 2022
|
FY2021
12 months to Sep 30, 2021
|
|
|---|---|---|---|---|---|
| Cash Provided by (Used in) Continuing Operation | |||||
| Operating activities: | |||||
| Net income | |||||
| Change in Accounting Method Accounted for as Change in Estimate | |||||
| Total net income | |||||
| Adjustments to arrive at cash provided by operating activities | |||||
| Depreciation | |||||
| Amortization of intangible assets | |||||
| Change in fair value of investments | |||||
| Share-based compensation expense | |||||
| Retirement benefit expense | |||||
| Pension contributions | |||||
| Deferred income taxes | |||||
| Net loss on disposition and impairment of property | |||||
| Settlement of interest rate derivatives | |||||
| Goodwill impairment | |||||
| Accounting method change for net legacy asbestos-related defense costs | |||||
| Goodwill and intangible asset impairment | |||||
| Changes in assets and liabilities, excluding effects of acquisitions and foreign currency adjustments | |||||
| Receivables | |||||
| Inventories | |||||
| Accounts payable | |||||
| Contract liabilities | |||||
| Compensation and benefits | |||||
| Income taxes | |||||
| Other assets and liabilities | |||||
| Cash provided by operating activities | |||||
| Investing activities: | |||||
| Capital expenditures | |||||
| Acquisition of businesses, net of cash acquired | |||||
| Purchases of investments | |||||
| Proceeds from sale of investments | |||||
| Other investing activities | |||||
| Cash (used for) provided by investing activities | |||||
| Financing activities: | |||||
| Net (repayment) issuance of short-term debt | |||||
| Issuance of short-term debt, net of issuance costs | |||||
| Issuance of long-term debt, net of discount and issuance costs | |||||
| Repayment of short-term debt | |||||
| Repayment of long-term debt | |||||
| Cash dividends | |||||
| Purchases of treasury stock | |||||
| Proceeds from the exercise of stock options | |||||
| Other financing activities | |||||
| Cash used for financing activities | |||||
| Effect of exchange rate changes on cash | |||||
| (Decrease) increase in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash at beginning of year | |||||
| Cash, cash equivalents, and restricted cash at end of year | |||||
| Components of cash, cash equivalents, and restricted cash | |||||
| Cash and cash equivalents | |||||
| Restricted cash, current (Other current assets) | |||||
| Restricted cash, noncurrent (Other assets) | |||||
Loading...